Auro Laboratories — Latest News

Every announcement Auro Laboratories has filed with the exchanges that we have reported, newest first. Each story links the original filing.

NSE: AUROLAB BSE: 530233 Pharmaceuticals & Biotechnology 2 stories

Price

₹249.05

Market Cap

₹155.22

Revenue TTM

₹28.40

P/E (TTM)

52.51×

Sector 40.81×

Reference data from Trendlyne, as of the most recent story. Not a valuation or a recommendation.

Regulatory Approval · 2
Regulatory Approval

Auro Laboratories Secures EDQM Approval for Metformin Hydrochloride Facility at Tarapur

Auro Laboratories Ltd receives EDQM Attestation of Inspection for its MIDC Tarapur facility, confirming EU GMP compliance for Metformin Hydrochloride…

Regulatory Approval

Auro Laboratories Secures Swissmedic GMP Compliance for Tarapur Plant; Revenue Up 207%

Auro Laboratories Ltd (530233) secures Swissmedic GMP certification for its Tarapur unit, aligning with EU-Switzerland standards for therapeutic prod…

Track Auro Laboratories in real time

ALFA Finder watches NSE & BSE filings 24/7 and alerts you the moment Auro Laboratories files something material.

Start Free — 15-day trial